APOA1 and bipolar disorder: In terms of metabolic indicators, patients with bipolar disorder and comorbid MAFLD showed significantly higher levels of glucose, ALT, ALP, TC, ApoB, triglycerides, and GGT, while exhibiting slightly lower levels of ApoA1 and significantly lower levels of HDL.